Author:
Barata Pedro C.,Cooney Matthew,Mendiratta Prateek,Tyler Allison,Dreicer Robert,Garcia Jorge A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference34 articles.
1. National Cancer Institute (2017) Surveillance Epidemiology, and end results program. Prostate Cancer. Retrieved from http://www.seer.cancer.gov . Accessed August 2018
2. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30
3. Sharifi N, Gulley JL, Dahut WL (2005) Androgen deprivation therapy for prostate cancer. Jama 294:238–244
4. Cheng HH, Lin DW, Yu EY (2012) Advanced clinical states in prostate cancer. Urol Clin North Am 39:561–571
5. Sweeney CJ, Chen Y-H, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS (2015) Chemohormonal therapy in metastatic hormone-sensitive prostate Cancer. N Engl J Med 373:737–746
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献